Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Invo Bioscience Inc (INVO)

Invo Bioscience Inc (INVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invo Bioscience Inc 5582 BROADCAST COURT SARASOTA FL 34240 USA

www.invobio.com P: 978-878-9505

Description:

INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.

Key Statistics

Overview:

Market Capitalization, $K 2,537
Enterprise Value, $K 9,557
Shares Outstanding, K 2,743
Annual Sales, $ 3,020 K
Annual Net Income, $ -8,030 K
Last Quarter Sales, $ 1,380 K
Last Quarter Net Income, $ -1,990 K
EBIT, $ -6,780 K
EBITDA, $ -5,860 K
60-Month Beta 1.48
% of Insider Shareholders 3.50%
% of Institutional Shareholders 12.02%
Float, K 2,647
% Float 96.50%
Short Volume Ratio 0.31

Growth:

1-Year Return -87.01%
3-Year Return -98.78%
5-Year Return -99.32%
5-Year Revenue Growth 516.33%
5-Year Earnings Growth 59.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.70 on 11/13/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -7.76
EPS Growth vs. Prev Qtr 77.12%
EPS Growth vs. Prev Year 83.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/28/23

INVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -265.89%
Debt/Equity 1.40
Price/Sales 0.85
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.36
Interest Coverage -7.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar